From: Four subgroups based on tau levels in Alzheimer’s disease observed in two independent cohorts
Biomarker: Platform | ADC p-tau Innotest | ||||
ADC T-tau: Innotest | Subgroup | 1 | 2 | 3 | 4 |
1 | 960 | 83 | 0 | 0 | |
2 | 140 | 661 | 58 | 0 | |
3 | 6 | 209 | 399 | 18 | |
4 | 0 | 0 | 33 | 60 | |
P-tau: Luminex | |||||
T-tau: Luminex | Subgroup | 1 | 2 | 3 | 4 |
1 | 210 | 108 | 13 | 1 | |
2 | 116 | 261 | 89 | 2 | |
3 | 3 | 159 | 138 | 8 | |
4 | 0 | 10 | 76 | 19 | |
P-tau: Elecsys | |||||
T-tau: Elecsys | Subgroup | 1 | 2 | 3 | 4 |
1 | 290 | 0 | 0 | 0 | |
2 | 186 | 309 | 0 | 0 | |
3 | 0 | 145 | 185 | 2 | |
4 | 0 | 0 | 14 | 61 | |
T-tau: Elecsys | |||||
T-tau: Luminex | Subgroup | 1 | 2 | 3 | 4 |
1 | 256 | 70 | 1 | 0 | |
2 | 35 | 381 | 43 | 1 | |
3 | 0 | 44 | 255 | 4 | |
4 | 0 | 0 | 33 | 70 | |
P-tau: Elecsys | |||||
P-tau: Luminex | Subgroup | 1 | 2 | 3 | 4 |
1 | 287 | 36 | 0 | 0 | |
2 | 167 | 296 | 63 | 2 | |
3 | 21 | 119 | 121 | 48 | |
4 | 0 | 1 | 13 | 12 |